Interview with the President and CEO: Radius Health Inc. (NASDAQ:RDUS)

Healthcare >> CEO Interviews >> February 12, 2016

Robert Ward is President and Chief Executive Officer of Radius Health, Inc. He is a global pharmaceutical industry leader managing all stages of drug development, commercialization, and strategic deal-making and partnerships across multiple therapeutic areas. Prior to joining Radius, Mr. Ward was Vice President for Strategy and External Alliances for the New Opportunities iMed of AstraZeneca, where he led search and evaluation activities in areas outside of AZ’s historical therapeutic focus, including orphan drugs and endocrinology. In addition, he served as Co-Chair of the Joint Development Committees in AZ’s drug development partnerships with Alcon and Galderma. After starting his career in the molecular biology discovery group at Genentech, Mr. Ward progressed through a series of management and executive roles with established biopharmaceutical companies, including NPS Pharmaceuticals, Schering-Plough — Merck — and Bristol-Myers Squibb. Mr. Ward received a B.A. in biology and a B.S. in physiological psychology, both from the University of California, Santa Barbara; an M.S. in management from the New Jersey Institute of Technology; and an M.A. in immunology from The Johns Hopkins University School of Medicine. Profile

TWST: Let's start with an introduction to Radius Health for our readers — the company’s historical background before its IPO.

Mr. Ward: When I think about

Join for free to read a longer excerpt or purchase this article

Interview with the President and CEO: Radius Health Inc. (NASDAQ:RDUS)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the President and CEO: Radius Health Inc. (NASDAQ:RDUS)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS